Pfizer in talks on $5 billion acquisition: media

Over 80,000 tourists trapped in ‘China’s Hawaii’ after COVID outbreak
7 August 2022
Long COVID symptoms affects one in eight, study suggests
7 August 2022

Pfizer in talks on $5 billion acquisition: media

American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.

Comments are closed.